Home › Regeneron Pharms Downgraded by Brean Murray
 

Keywords :   


Regeneron Pharms Downgraded by Brean Murray

2013-01-18 05:36:43| Biotech - Topix.net

A number of other firms have also recently commented on REGN. Analysts at Robert W. Baird raised their price target on shares of Regeneron Pharms from $176.00 to $205.00 in a research note to investors on Tuesday.

Tags: murray downgraded brean regeneron

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
28.09Eastern North Pacific Tropical Weather Outlook
28.09Atlantic Tropical Weather Outlook
28.09Post-Tropical Cyclone Helene Public Advisory Number 21
28.09Tropical Storm Joyce Public Advisory Number 5
28.09Summary for Tropical Storm Joyce (AT1/AL112024)
28.09Post-Tropical Cyclone Helene Public Advisory Number 21
28.09Tropical Storm Joyce Forecast Discussion Number 5
28.09Tropical Storm Joyce Wind Speed Probabilities Number 5
More »